Previous Article | Next Article ![]()
Applied and Environmental Microbiology, April 2003, p. 2306-2312, Vol. 69, No. 4
0099-2240/03/$08.00+0 DOI: 10.1128/AEM.69.4.2306-2312.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Institute of Biochemistry, National Yang-Ming University, Taipei,1 Synmax Biochemical Co., Ltd., Hsinchu,2 Department of Life Sciences, National Tsing-Hua University, Hsinchu, Taiwan3
Received 16 September 2002/ Accepted 15 January 2003
The deacetoxycephalosporin C synthase (DAOCS) from Streptomyces clavuligerus was engineered with the aim of enhancing the conversion of penicillin G into phenylacetyl-7-aminodeacetoxycephalosporanic acid, a precursor of 7-aminodeacetoxycephalosporanic acid, for industrial application. A single round of random mutagenesis followed by the screening of 5,500 clones identified three mutants, G79E, V275I, and C281Y, that showed a two- to sixfold increase in the kcat/Km ratio compared to the wild-type enzyme. Site-directed mutagenesis to modify residues surrounding the substrate resulted in three mutants, N304K, I305L, and I305M, with 6- to 14-fold-increased kcat/Km values. When mutants containing all possible combinations of these six sites were generated to optimize the ring expansion activity for penicillin G, the double mutant, YS67 (V275I, I305M), showed a significant 32-fold increase in the kcat/Km ratio and a 5-fold increase in relative activity for penicillin G, while the triple mutant, YS81 (V275I, C281Y, I305M), showed an even greater 13-fold increase in relative activity toward penicillin G. Our results demonstrate that this is a robust approach to the modification of DAOCS for an optimized DAOCS-penicillin G reaction.
This article has been cited by other articles:
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»